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Abstract
Background: While progress in the prevention of cardiovascular disease (CVD) has been noted 
over the past several decades, there are still those who develop CVD earlier in life than others.
Objective: We investigated traditional and lifestyle CVD risk factors in young to middle-aged 
patients compared to older ones with obstructive coronary artery disease (CAD).
Methods: A retrospective analysis of patients with a new diagnosis of obstructive CAD 
undergoing coronary intervention was performed. Young to middle-aged patients were defined as 
those in the youngest quartile (n = 281, mean age 50 ± 6 years, 81% male) compared to the other 
three older quartiles combined (n = 799, mean age 69 ± 7.5 years, 71% male). Obstructive CAD 
was determined by angiography.
Results: Young to middle-aged patients compared to older ones were more likely to be male (p < 
0.01), smokers (21 vs. 9%, p < 0.001), and have a higher body mass index (31 ± 6 vs. 29 ± 6 
kg/m2, p < 0.001). Younger patients were less likely to eat fruits, vegetables, and fish and had 
fewer controlled CVD risk factors (2.7 ± 1.2 vs. 3.0 ± 1.0, p < 0.001). Compared to older patients, 
higher levels of psychological stress (aOR 1.6, 95% CI 1.1–2.4), financial stress (aOR 1.8, 95% CI 
1.3–2.5), and low functional capacity (aOR 3.3, 95% CI 2.4–4.5) were noted in the young to 
middle-aged population as well.
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Conclusion: Lifestyle in addition to traditional CVD risk factors should be taken into account 
when evaluating risk for development of CVD in a younger population.
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Introduction
During the last three decades, primary and secondary prevention efforts have led to a 
considerable decline in cardiovascular disease (CVD) and coronary heart disease incidence 
and mortality in the US [1]. However, recently the rate of decline in age-adjusted CVD and 
coronary heart disease mortality rates has slowed [2]. Particularly concerning are the trends 
of acute myocardial infarction hospitalization and mortality rates among young to middle-
aged adults (<55 years of age), where rates have not declined over the past decade [3].
In line with this, studies in the young to middle-aged US population have documented an 
increased prevalence of obesity, diabetes mellitus (DM), and stagnation in the improvement 
of lipid levels, all in the setting of suboptimal lifestyle behaviors such as poor diet, decreased 
physical activity, and increased rates of smoking [1, 4]. These CVD trends in young to 
middle-aged adults suggest the need for improved identification and treatment of high-risk 
individuals. Furthermore, the currently employed CVD risk assessment tools focusing on 
10-year CVD risk calculation are heavily age-weighted and have been shown to 
underestimate CVD risk in the young to middle-aged populations [5, 6].
The main objective of this analysis was to assess CVD risk factor control and lifestyle 
factors associated with a new diagnosis of obstructive coronary artery disease (CAD) in 
young to middle-aged patients compared to older ones undergoing cardiovascular (CV) 
procedures. Additionally, because lifestyle factors are not components of a traditional 
cardiac risk score for primary prevention risk stratification, recognizing and clarifying these 
factors may further guide CVD risk assessment and targeted preventive measures for young 
to middle-aged patients with less favorable trends in CVD outcomes [7–10].
Methods
The New York University Langone Health Preventive Cardiology Inpatient Consult Service 
[11, 12] was established in 2010 as an effort to optimize CVD risk factor control of patients 
undergoing elective CV procedures. We performed a retrospective analysis of patients 
undergoing preventive cardiology consultation after elective coronary angiography along 
with coronary intervention from November 2010 through October 2017 (entire cohort, n = 
2,385, average age 66.5 ± 25 years, 75% male, 67% white). We excluded patients with a pre-
existing diagnosis of CVD defined as a self-reported or chart diagnosis of CVD (e.g., prior 
history of myocardial infarction [MI], coronary or lower extremity intervention). A total of 
1,088 patients (average age 64 ± 11 years, 74% male, 68% white) met these criteria.
Demographics, anthropometrics, past medical history, including hypertension (HTN), 
hypercholesterolemia (HLD), DM, and medications were obtained by chart review, 
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administrative ICD-9/10 codes, and by direct patient interview conducted during the CVD 
prevention consultation immediately post coronary angiography. Blood pressure was 
recorded at the time of the prevention consult interview, after coronary angiography. All 
laboratory data were recorded immediately post coronary angiography or within 2 weeks 
prior to the procedure (lipids, creatinine, hemoglobin A1c [HbA1c]). A new diagnosis of 
obstructive CAD was determined as undergoing a coronary intervention or having ≥ 1 
coronary lesion with ≥ 70% stenosis (≥ 50% for left main) on angiography and not having 
pre-existing CVD (as defined above).
Traditional CVD risk factors were considered to be those included in CVD risk scoring 
systems (HTN, HLD, DM, smoking) as well as body mass index (BMI). Lifestyle CVD risk 
factors included dietary intake, functional capacity, and levels of stress (both financial and 
personal) and were assessed according to a previously published protocol [11]. Briefly, diet 
was assessed using an in-house food frequency questionnaire that focused on daily fruit, 
vegetable, sweetened beverage, and weekly fish intake as noted in the American Heart 
Association (AHA) guideline recommendations [13]. Physical activity was assessed by 
relative functional capacity defined by the Duke Activity Status Index (DASI) [14]. The 
DASI consists of 12 questions to evaluate the ability to perform a variety of physical 
activities and ranges from a score of 0 to 58.2 (high functional capacity). Each DASI score 
was converted into age- and sex-specific metabolic equivalents (METS), referenced to 
predicted METS for age and sex and then reported as the actual METS/predicted METs × 
100. Predicted METS levels ≥85% are considered an ideal level of functional capacity, 
where <85% is considered an intermediate or poor level [14]. Psychosocial questions were 
adapted from INTERHEART study methodology and included questions on feelings of 
depression, in addition to levels of financial and personal stress [11]. Significant financial 
stress was defined as frequent feelings of moderate or severe financial stress (as compared to 
little or none), while significant personal stress was defined as several or permanent periods 
of stress (as compared to never or some periods).
The degree to which CVD risk factors (both traditional and lifestyle) were controlled was 
defined as “CV health factors at goal” and determined through recommendations set for the 
primary prevention of CVD by the AHA to follow “Life’s Simple 7” [4, 15]. This included a 
BMI <25 kg/m2, systolic blood pressure <120 mm Hg, total cholesterol <200 mg/dL, 
healthy eating habits (2 out of 3 of either: ≥4.5 cups/day of fruits and/or vegetables, ≥2 
servings fish/week, <8 ounces of sweetened beverages/day), nonsmoking status, HbA1c 
<7.0%, or physical activity ≥85% METS of predicted activity for age and gender.
In order to specifically investigate “younger” patients, age was categorized into quartiles 
across the entire cohort of patients presenting with a new diagnosis of obstructive CAD. 
Younger patients in the cohort were defined as the first quartile (25–57 years of age) – 
termed young to middle aged. This was compared to the last three quartiles combined (58–
96 years of age).
Descriptive analysis of all patient characteristics comparing the first to the remaining three 
quartiles was performed with a t test or Mann-Whitney U test for continuous variables as 
appropriate and a χ2 test for categorical variables. Logistic regression was used to assess 
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lifestyle factors associated with younger age at first presentation of obstructive CAD 
(dependent variable). Multivariable models were adjusted for sex, obesity, HTN, HLD, 
active smoking, and DM. Interaction terms were tested between each lifestyle factor and sex 
by creating a cross-product term in the multivariable model. All statistical analysis was 
performed using STATA v.11 (StataCorp, College Station, TX, USA). A 2-sided alpha error 
<0.05 indicted statistical significance. This study was conducted in accordance with and 
approval of the NYU Langone Health institutional review board.
Results
Descriptive characteristics of the study population are listed in Table 1. Among 1,088 
patients presenting with a new diagnosis of obstructive CAD, young to middle-aged patients 
(first quartile; 50 ± 6 years) compared to the older three quartiles (69 ± 7.5 years) were more 
likely to be male, active smokers, obese, and less likely to have pre-existing HTN (Table 1; 
see online suppl. Table 1; for all online suppl. material, see www.karger.com/doi/
10.1159/000498891). The number of traditional CVD risk factors including HLD and DM 
were similar in the young to middle-aged patients compared to the other three quartiles; 
however, younger patients had higher levels of both total and LDL cholesterol, higher 
diastolic and lower systolic blood pressure measurements and were less likely to be treated 
with aspirin and lipid-lowering (statin) therapy at the time of coronary angiography. When 
assessing the degree of obstructive CAD, there was no difference in the number of vessels 
affected in young to middle-aged patients compared to older ones (Table 1).
When assessing lifestyle CVD risk factors, young to middle-aged patients were more likely 
to have higher levels of personal and financial stress and lower functional capacity (Table 1). 
The dietary intake of these patients was also less optimal when compared to older patients 
including less fruit, vegetable, and fish intake as well as a higher proportion of sweetened 
beverage intake compared to older patients (Tables 1 and 2; online suppl. Table 1).
Overall, young to middle-aged patients with a new diagnosis of obstructive CAD had 
significantly fewer CV health factors at goal when compared to older patients (Table 2; Fig. 
1). These younger patients were more likely to be overweight or obese, to be active smokers, 
and to have a higher blood pressure as well as higher cholesterol levels than older patients. 
They also had lower functional capacity compared to older patients, and a lower percentage 
followed the AHA recommendations for a healthy diet in terms of fruit, vegetable, fish, and 
sweetened beverage intake (Table 2).
In univariable analysis assessing the association between lifestyle factors and age, compared 
to older patients, young to middle-aged patients had a higher odds of personal stress (OR, 
1.8; 95% CI 1.3–2.5), financial stress (OR, 1.8; 95% CI 1.3–2.4), and lower functional 
capacity (OR, 3.1; 95% CI 2.4–4.1). The young to middle-aged patients had higher odds of 
low consumption of fruit (OR, 1.7; 95% CI 1.1–2.4), vegetables (OR, 1.9; 95% CI 1.2–2.9), 
and fish (OR, 1.5 95% CI 1.0–2.0), as well as greater sweetened beverage intake (OR, 1.6; 
95% CI 1.2–2.3) (Table 3). Aside from fruit intake, these associations remained unchanged 
after adjustment for traditional CVD risk factors such as sex, obesity, HTN, HLD, DM, and 
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active smoking. No interaction was noted between these lifestyle factors and sex (p > 0.05; 
Table 3).
Discussion
In this retrospective analysis of patients with a new diagnosis of obstructive CAD, young to 
middle-aged patients compared to older ones had worse dietary patterns and lower rates of 
controlled CV health factors including higher BMI, worse lipid measurements, and active 
smoking. Also noted were higher rates of CVD risk factors not accounted for in traditional 
CVD risk scoring systems such as personal and financial stress and low functional capacity. 
At the time of catheterization, compared to older patients, young to middle-aged patients 
were less frequently on aspirin and statin therapy.
Our findings, including low rates of CVD prevention therapy, are consistent with recent 
analysis of the Young-MI registry, where the majority of young adults presenting with an MI 
would not have met guideline-based criteria for prevention medications, such as statins, prior 
to their MI [16]. An estimated 85–90% of CVD risk is attributed to traditional CVD risk 
factors [17] as well as a 4–5 times increased lifetime CVD risk [4, 6, 18]. Consistent with 
the Young-MI registry, our analysis suggests that one potential mechanisms for CVD in the 
younger cohort is a potentially underrecognized CVD risk. However, based on the available 
data in our analysis, this observation would have to be investigated in future studies.
These young to middle-aged patients also had a significantly poorer CV health factor control 
as defined by AHA guideline recommendations [15]. This suggests that in addition to 
traditional CVD risk factor recognition and treatment, a focus on lifestyle factors which are 
upstream in the causal pathway of CVD may guide more effective preventive counseling, 
particularly in younger individuals [19]. For example, we found that failure to attain a 
healthy lifestyle significantly correlated with obstructive CAD at a younger age. Self-
reported adherence to a healthy diet of fruits, vegetables, and fish intake was significantly 
less in the young to middle-aged compared to older patient cohort. These younger patients 
also had a notably low functional capacity, a significant concern as these findings correlate 
with poor health and risk for poor outcomes [14, 20].
The increased level of perceived personal and financial stress noted in the younger cohort is 
also of interest. Studies have previously noted the connection between stress and CVD [21]. 
Stress has been linked to lower levels of physical activity, smoking, and CV medication 
adherence which may explain the association with CVD [22]. Biologically, stress has also 
been linked to systemic inflammatory processes which may influence the pathogenesis of 
atherosclerosis [22, 23]. Finally, how age influences the relationship between psychosocial 
factors and CVD has remained unclear [24, 25]. Our study builds on previous studies by 
finding that both perceived financial and personal stress was preferentially associated with 
CAD at a younger age [26, 27].
In our analysis, we also noted elevated diastolic and lower systolic blood pressure 
measurements in the young to middle-aged compared to older patient population. Given the 
real-world setting of our prevention registry where blood pressure was measured post 
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cardiac catheterization, it is unclear what the significance of these findings are. National 
Health and Nutrition Examination Survey (NHANES) data have shown a higher prevalence 
of untreated isolated diastolic HTN in middle-aged compared to older adults, where as 
expected, isolated systolic HTN was highest in older individuals [28]. Expanding on this, 
analysis of young adults with HTN over a follow-up of more than 20 years, men (who make 
up the majority of our registry) with a diagnosis of isolated diastolic HTN had a similar 
incidence of CVD mortality when compared to systolic-diastolic HTN and a higher 
incidence of CVD mortality compared to isolated systolic HTN [29]. Our findings of higher 
diastolic and lower systolic blood pressure in the young to middle-aged cohort should be 
further investigated in studies assessing CVD risk in younger populations.
Overall, favorable traditional and lifestyle CVD risk factor control is important as it can have 
lasting impact, potentially reducing the incidence of CVD [30]. The World Health 
Organization (WHO) has recognized the need for optimal CVD risk factor control, having 
set worldwide goals of reduced premature CVD mortality (defined as between 30–70 years 
of age) [31]. Predictive models by the WHO reveal that CVD deaths can be reduced by 25% 
through recognition and improvement of CVD risk factors such as HTN, DM, HLD, obesity, 
smoking, and physical inactivity [31]. For example, studies such as the Coronary Artery 
Risk Development in Young Adults (CARDIA) have noted that healthy lifestyle changes at 
the age of 20 years were correlated with reduced odds of atherosclerosis 30 years later [32].
Building on this concept of lifetime CVD risk reduction strategies, the findings of 
suboptimal CVD risk factor control and lack of CV health factors at goal in the younger 
cohort have implications for the lifetime CVD risk as poor lifestyle choices are compounded 
over time [33]. It also represents an opportunity to further modify risk among young to 
middle-age patients to improve adverse health outcomes [34]. Specifically, our study helps 
inform preventive counseling efforts in younger middle-aged adults, especially since 
traditional CVD risk factors often underestimate the 10-year CVD risk in these individuals 
[5].
Our study has several limitations. First, this was a cross-sectional analysis and we can 
therefore only assess association and not causation. Our sample represents a patient 
population at a single, major medical center targeted for cardiac prevention counseling with 
reasons for cardiac catheterization referral unknown. Our study population was also 
predominantly male and Caucasian, a feature which may limit the external validity. 
Additionally, we used self-administered dietary surveys based on AHA heart healthy 
recommendations and therefore the dietary responses may not have been as accurate as other 
validated food frequency questionnaires. Finally, questions on depression and psychosocial 
well-being were carried out as part of clinical care as opposed to a research environment. 
While this may not be sufficient for an in-depth etiologic exploration of psychosocial 
stressors, it illustrates a particular CVD risk factor profile and raises awareness of the 
potential value of further CVD risk assessment in the young to middle-aged population. The 
strengths of our study are that we assessed a large number of patients and we used an 
angiographically confirmed new diagnosis of obstructive CAD in order to specifically 
understand the associations of various factors with an earlier onset of obstructive CAD.
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Conclusion
In summary, we found that young to middle-aged patients compared to older ones with a 
new diagnosis of obstructive CAD had less well-controlled CVD risk factors in addition to 
worse diet, more stress, and lower functional capacity. The associations noted in this 
analysis build on previous studies exploring CVD risk factors and risk factor control in the 
young and highlight the need for investigations to determine if targeting each will improve 
CVD risk specifically in the young to middle-aged population. Considering that existing risk 
prediction tools are suboptimal in the young, perhaps a traditional risk calculator combined 
with a lifestyle assessment can improve risk prediction and uncover opportunities for 
preventive measures in this population.
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Fig. 1. 
Diagram showing controlled CV health factors in younger to middle-aged patients compared 
to older ones newly diagnosed with obstructive CAD. Young to middle-aged patients 
presenting with a new diagnosis of obstructive CAD had less CV health factors at goal 
compared to older ones. The mean number of CVD health factors at goal was 2.7 ± 1.2 in 
the youngest quartile and 3.0 ± 1.0 in the other three quartiles combined (p < 0.001). CV 
health factors at goal were defined using the American Heart Association Life’s Simple 7 
recommendations.
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